Recent progress on diabetes mellitus after liver transplantation
10.3969/j.issn.1674-7445.2021.05.020
- VernacularTitle:肝移植术后糖尿病的最新进展
- Author:
Zhengnan XIAO
1
;
Junhui LI
;
Jie JIANG
;
Zhaoqin ZHOU
;
Yu ZHANG
;
Chen GUO
;
Meng WANG
;
Yingzi MING
Author Information
1. Transplantation Center, the Third Xiangya Hospital of Central South University, Engineering and Technology Research Center of Organ Transplantation, National Health Commission of China, Changsha 410013, China
- Publication Type:Research Article
- Keywords:
Liver transplantation;
Post-transplantation diabetes mellitus (PTDM);
Glucocorticoid;
Calcineurin inhibitor;
Mammalian target of rapamycin;
Rejection;
Chronic liver disease;
Insulin
- From:
Organ Transplantation
2021;12(5):630-
- CountryChina
- Language:Chinese
-
Abstract:
Diabetes mellitus is one of the most common complications after liver transplantation. The survival rate of recipients after liver transplantation with diabetes mellitus and the long-term survival rate of grafts are significantly lower than those of their counterparts without diabetes mellitus. In recent years, diabetes mellitus after liver transplantation has attracted widespread attention along with the rapid development of liver transplantation in China. Although post-transplantation diabetes mellitus (PTDM) has been extensively investigated in the past two decades, multiple problems remain to be further resolved. The study was designed to review the latest research progress upon diabetes mellitus after liver transplantation, covering the definition and diagnostic criteria of PTDM, risk factors, prevention and treatment of diabetes mellitus after liver transplantation, aiming to deepen the understanding of diabetes mellitus following liver transplantation, deliver effective prevention and management, improve the long-term survival rate and enhance the quality of life of the recipients.
